AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
AXT, Inc. (AXTI) surged 9.60% on September 19, 2025, marking a two-day rally of 10.15% and reaching an intraday high of 12.63%, its highest level since September 2025. The stock’s momentum reflects renewed confidence in the company’s operational and regulatory progress.
A critical catalyst emerged as AXTI’s China-based unit secured export permits for gallium arsenide (GaAs) and germanium substrates on September 20, 2025. This development resolves a prior bottleneck caused by export restrictions, enabling shipments critical for 5G infrastructure and photonic applications. Analysts view this as a stabilization factor for near-term revenue and a positive signal for Q3 2025 performance, given AXTI’s reliance on China for high-purity materials.
Institutional activity further underscored optimism. Granahan Investment Management LLC increased holdings on September 11, 2025, while Perritt Capital Management Inc. added a $50,000 position on September 8, 2025. With 53% institutional ownership, these moves highlight strategic interest in AXTI’s role in semiconductor materials for 5G and AI-driven technologies.
Analyst sentiment remained cautiously bullish, with a “Moderate Buy” consensus on September 19, 2025, and a “Strong Buy” rating from Needham & Company LLC in August. Price targets, including a $4.60 target (5.99% above the closing price), reflect confidence in AXTI’s technical capabilities and long-term growth in photonic and AI markets.
Geopolitical risks linger, as AXTI’s operations remain sensitive to U.S.-China trade dynamics. While recent regulatory alignment eased short-term concerns, future export restrictions could disrupt supply chains. However, reduced short interest and active investor engagement, including Q2 2025 earnings webinars, signal improving market confidence in the company’s resilience.

Knowing stock market today at a glance

Dec.24 2025

Dec.24 2025

Dec.24 2025

Dec.24 2025

Dec.24 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet